NET LOSS PER SHARE (Details) - Schedule of dilutive shares - shares	12 Months Ended
Dec. 31, 2021	Dec. 31, 2020
Anti-dilutive shares	81,477,436	107,775,249
Convertible debt [Member]
Anti-dilutive shares	13,626,666	56,486,677
Stock options [Member]
Anti-dilutive shares	30,516,666	100,000
Warrants to purchase shares of common stock [Member]
Anti-dilutive shares	37,304,104	51,188,572

Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257

Name:	us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
Namespace Prefix:	us-gaap_
Data Type:	xbrli:sharesItemType
Balance Type:	na
Period Type:	duration